Literature DB >> 27632065

Pharmacokinetic Modeling of Paracetamol Uptake and Clearance in Zebrafish Larvae: Expanding the Allometric Scale in Vertebrates with Five Orders of Magnitude.

Vasudev Kantae1, Elke H J Krekels2, Anita Ordas3, Oskar González1,4, Rob C van Wijk2, Amy C Harms1, Peter I Racz5, Piet H van der Graaf2, Herman P Spaink3, Thomas Hankemeier1.   

Abstract

Zebrafish larvae (Danio rerio) are increasingly used to translate findings regarding drug efficacy and safety from in vitro-based assays to vertebrate species, including humans. However, the limited understanding of drug exposure in this species hampers its implementation in translational research. Using paracetamol as a paradigm compound, we present a novel method to characterize pharmacokinetic processes in zebrafish larvae, by combining sensitive bioanalytical methods and nonlinear mixed effects modeling. The developed method allowed quantification of paracetamol and its two major metabolites, paracetamol-sulfate and paracetamol-glucuronide in pooled samples of five lysed zebrafish larvae of 3 days post-fertilization. Paracetamol drug uptake was quantified to be 0.289 pmole/min and paracetamol clearance was quantified to be 1.7% of the total value of the larvae. With an average volume determined to be 0.290 μL, this yields an absolute clearance of 2.96 × 107 L/h, which scales reasonably well with clearance rates in higher vertebrates. The developed methodology will improve the success rate of drug screens in zebrafish larvae and the translation potential of findings, by allowing the establishment of accurate exposure profiles and thereby also the establishment of concentration-effect relationships.

Entities:  

Keywords:  allometry; drug discovery; metabolism; paracetamol; pharmacokinetics; zebrafish

Mesh:

Substances:

Year:  2016        PMID: 27632065      PMCID: PMC5124745          DOI: 10.1089/zeb.2016.1313

Source DB:  PubMed          Journal:  Zebrafish        ISSN: 1545-8547            Impact factor:   1.985


  23 in total

1.  Piraña and PCluster: a modeling environment and cluster infrastructure for NONMEM.

Authors:  Ron J Keizer; Michel van Benten; Jos H Beijnen; Jan H M Schellens; Alwin D R Huitema
Journal:  Comput Methods Programs Biomed       Date:  2010-06-02       Impact factor: 5.428

2.  An investigation of the bioactivation potential and metabolism profile of Zebrafish versus human.

Authors:  Hui Ting Chng; Han Kiat Ho; Chun Wei Yap; Siew Hong Lam; Eric Chun Yong Chan
Journal:  J Biomol Screen       Date:  2012-05-29

3.  PsN-Toolkit--a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM.

Authors:  Lars Lindbom; Pontus Pihlgren; E Niclas Jonsson; Niclas Jonsson
Journal:  Comput Methods Programs Biomed       Date:  2005-09       Impact factor: 5.428

4.  A novel hydroxysteroid-sulfating cytosolic sulfotransferase, SULT3 ST3, from zebrafish: identification, characterization, and ontogenic study.

Authors:  Shin Yasuda; Meredith Burgess; Tomoko Yasuda; Ming-Yih Liu; Shakhawat Bhuiyan; Frederick E Williams; Katsuhisa Kurogi; Yoichi Sakakibara; Masahito Suiko; Ming-Cheh Liu
Journal:  Drug Metab Lett       Date:  2009-12

5.  Metabolism of calycosin, an isoflavone from Astragali Radix, in zebrafish larvae.

Authors:  Guang Hu; Shiu On Siu; Shang Li; Ivan Keung Chu; Yiu Wa Kwan; Shun Wan Chan; George Pak-Heng Leung; Ru Yan; Simon Ming-Yuen Lee
Journal:  Xenobiotica       Date:  2011-10-02       Impact factor: 1.908

6.  Pharmacokinetics and metabolism of rectally administered paracetamol in preterm neonates.

Authors:  R A van Lingen; J T Deinum; J M Quak; A J Kuizenga; J G van Dam; K J Anand; D Tibboel; A Okken
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-01       Impact factor: 5.747

Review 7.  Zebrafish as a model to explore cell metabolism.

Authors:  Massimo M Santoro
Journal:  Trends Endocrinol Metab       Date:  2014-07-02       Impact factor: 12.015

Review 8.  Zebrafish as tools for drug discovery.

Authors:  Calum A MacRae; Randall T Peterson
Journal:  Nat Rev Drug Discov       Date:  2015-09-11       Impact factor: 84.694

9.  Identification and developmental expression of the full complement of Cytochrome P450 genes in Zebrafish.

Authors:  Jared V Goldstone; Andrew G McArthur; Akira Kubota; Juliano Zanette; Thiago Parente; Maria E Jönsson; David R Nelson; John J Stegeman
Journal:  BMC Genomics       Date:  2010-11-18       Impact factor: 3.969

Review 10.  Zebrafish as model organisms for studying drug-induced liver injury.

Authors:  A D Bastiaan Vliegenthart; Carl S Tucker; Jorge Del Pozo; James W Dear
Journal:  Br J Clin Pharmacol       Date:  2014-12       Impact factor: 4.335

View more
  17 in total

Review 1.  Let's get small (and smaller): Combining zebrafish and nanomedicine to advance neuroregenerative therapeutics.

Authors:  David T White; Meera T Saxena; Jeff S Mumm
Journal:  Adv Drug Deliv Rev       Date:  2019-02-12       Impact factor: 15.470

2.  Assaying uptake of endocrine disruptor compounds in zebrafish embryos and larvae.

Authors:  J Paige Souder; Daniel A Gorelick
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2017-09-21       Impact factor: 3.228

3.  Quantification of Estradiol Uptake in Zebrafish Embryos and Larvae.

Authors:  Jaclyn Paige Souder; Daniel A Gorelick
Journal:  Toxicol Sci       Date:  2017-08-01       Impact factor: 4.849

4.  Impact of Lysosomal Fraction on Melanin Synthesis Inhibition in a Zebrafish Melanogenesis Phenotype Model.

Authors:  Gyeongchan Jeon; Yang-Hoon Kim; Jiho Min
Journal:  Mol Biotechnol       Date:  2022-05-30       Impact factor: 2.860

5.  Mass spectrometry imaging in zebrafish larvae for assessing drug safety and metabolism.

Authors:  Mariana Asslan; Nidia Lauzon; Maja Beus; Dusica Maysinger; Simon Rousseau
Journal:  Anal Bioanal Chem       Date:  2021-06-26       Impact factor: 4.142

6.  Anti-tuberculosis effect of isoniazid scales accurately from zebrafish to humans.

Authors:  Rob C van Wijk; Wanbin Hu; Sharka M Dijkema; Dirk-Jan van den Berg; Jeremy Liu; Rida Bahi; Fons J Verbeek; Ulrika S H Simonsson; Herman P Spaink; Piet H van der Graaf; Elke H J Krekels
Journal:  Br J Pharmacol       Date:  2020-11-03       Impact factor: 8.739

7.  Recent developments in in vitro and in vivo models for improved translation of preclinical pharmacokinetics and pharmacodynamics data.

Authors:  Jaydeep Yadav; Mehdi El Hassani; Jasleen Sodhi; Volker M Lauschke; Jessica H Hartman; Laura E Russell
Journal:  Drug Metab Rev       Date:  2021-05-25       Impact factor: 6.984

Review 8.  Zebrafish, an In Vivo Platform to Screen Drugs and Proteins for Biomedical Use.

Authors:  Hung-Chieh Lee; Cheng-Yung Lin; Huai-Jen Tsai
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-24

Review 9.  Quo natas, Danio?-Recent Progress in Modeling Cancer in Zebrafish.

Authors:  Stefanie Kirchberger; Caterina Sturtzel; Susana Pascoal; Martin Distel
Journal:  Front Oncol       Date:  2017-08-28       Impact factor: 6.244

10.  Outside-In Systems Pharmacology Combines Innovative Computational Methods With High-Throughput Whole Vertebrate Studies.

Authors:  Pascal Schulthess; Rob C van Wijk; Elke H J Krekels; James W T Yates; Herman P Spaink; Piet H van der Graaf
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2018-04-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.